β-hydroxybutyrate based therapeutic (Selah Therapeutics/Juvenescence)

N/A

Report date: 2025/03/20 09:52:00
NME

Base Information

Drug Nameβ-hydroxybutyrate based therapeutic (Selah Therapeutics/Juvenescence)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart FailureHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBritish Virgin IslandsUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSelah Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBuck InstituteJuvenescence LtdSelah Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsHeart FailureHeart Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A